Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 283

1.

Correction to: Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance.

Berencsi K, Sami A, Ali MS, Marinier K, Deltour N, Perez-Gutthann S, Pedersen L, Rijnbeek P, Van der Lei J, Lapi F, Simonetti M, Reyes C, Sturkenboom MCJM, Prieto-Alhambra D.

Osteoporos Int. 2020 Feb 5. doi: 10.1007/s00198-020-05314-2. [Epub ahead of print]

PMID:
32025756
2.

Big Data in the Assessment of Pediatric Medication Safety.

McMahon AW, Cooper WO, Brown JS, Carleton B, Doshi-Velez F, Kohane I, Goldman JL, Hoffman MA, Kamaleswaran R, Sakiyama M, Sekine S, Sturkenboom MCJM, Turner MA, Califf RM.

Pediatrics. 2020 Feb;145(2). pii: e20190562. doi: 10.1542/peds.2019-0562. Epub 2020 Jan 14.

PMID:
31937606
3.

Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance.

Berencsi K, Sami A, Ali MS, Marinier K, Deltour N, Perez-Gutthann S, Pedersen L, Rijnbeek P, Van der Lei J, Lapi F, Simonetti M, Reyes C, Sturkenboom MCJM, Prieto-Alhambra D.

Osteoporos Int. 2019 Nov 6. doi: 10.1007/s00198-019-05181-6. [Epub ahead of print] Erratum in: Osteoporos Int. 2020 Feb 5;:.

PMID:
31696274
4.

Hair cortisol and inhaled corticosteroid use in asthmatic children.

Baan EJ, van den Akker ELT, Engelkes M, de Rijke YB, de Jongste JC, Sturkenboom MCJM, Verhamme KM, Janssens HM.

Pediatr Pulmonol. 2020 Feb;55(2):316-321. doi: 10.1002/ppul.24551. Epub 2019 Oct 25.

5.

Description of the Risk Management of Medication Errors for Centrally Authorised Products in the European Union.

Hoeve CE, Francisca RDC, Zomerdijk I, Sturkenboom MCJM, Straus SMJM.

Drug Saf. 2020 Jan;43(1):45-55. doi: 10.1007/s40264-019-00874-7.

6.

Exploratory Study of Signals for Asthma Drugs in Children, Using the EudraVigilance Database of Spontaneous Reports.

Baan EJ, de Smet VA, Hoeve CE, Pacurariu AC, Sturkenboom MCJM, de Jongste JC, Janssens HM, Verhamme KMC.

Drug Saf. 2020 Jan;43(1):7-16. doi: 10.1007/s40264-019-00870-x.

7.

EU postmarket surveillance plans for medical devices.

Pane J, Francisca RDC, Verhamme KMC, Orozco M, Viroux H, Rebollo I, Sturkenboom MCJM.

Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1155-1165. doi: 10.1002/pds.4859. Epub 2019 Jul 18. Review.

8.

Generating and evaluating a propensity model using textual features from electronic medical records.

Afzal Z, Masclee GMC, Sturkenboom MCJM, Kors JA, Schuemie MJ.

PLoS One. 2019 Mar 4;14(3):e0212999. doi: 10.1371/journal.pone.0212999. eCollection 2019.

9.

Antibiotic use in children with asthma: cohort study in UK and Dutch primary care databases.

Baan EJ, Janssens HM, Kerckaert T, Bindels PJE, de Jongste JC, Sturkenboom MCJM, Verhamme KMC.

BMJ Open. 2018 Nov 28;8(11):e022979. doi: 10.1136/bmjopen-2018-022979.

10.

Spontaneous reports of vaccination errors in the European regulatory database EudraVigilance: A descriptive study.

Hoeve CE, van Haren A, Sturkenboom MCJM, Straus SMJM.

Vaccine. 2018 Dec 18;36(52):7956-7964. doi: 10.1016/j.vaccine.2018.11.003. Epub 2018 Nov 8.

11.

Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK.

Gadroen K, Dodd CN, Masclee GMC, de Ridder MAJ, Weibel D, Mina MJ, Grenfell BT, Sturkenboom MCJM, van de Vijver DAMC, de Swart RL.

BMJ Open. 2018 Nov 8;8(11):e021465. doi: 10.1136/bmjopen-2017-021465.

12.

Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project.

Masclee GMC, Straatman H, Arfè A, Castellsague J, Garbe E, Herings R, Kollhorst B, Lucchi S, Perez-Gutthann S, Romio S, Schade R, Schink T, Schuemie MJ, Scotti L, Varas-Lorenzo C, Valkhoff VE, Villa M, Sturkenboom MCJM.

PLoS One. 2018 Nov 1;13(11):e0204746. doi: 10.1371/journal.pone.0204746. eCollection 2018.

13.

Comparing drug effectiveness in children: A systematic review.

Dukanovic J, Osokogu OU, Patel K, Ferrajolo C, Sturkenboom MCJM; Global Research in Pediatrics project.

Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1295-1301. doi: 10.1002/pds.4676. Epub 2018 Oct 31.

PMID:
30379371
14.

Measuring the impact of the 2012 European pharmacovigilance legislation on additional risk minimization measures.

Francisca RDC, Zomerdijk IM, Sturkenboom MCJM, Straus SMJM.

Expert Opin Drug Saf. 2018 Oct;17(10):975-982. doi: 10.1080/14740338.2018.1512579. Epub 2018 Aug 22.

PMID:
30107752
15.

Impact of different assumptions on estimates of childhood diseases obtained from health care data: A retrospective cohort study.

Osokogu OU, Pacurariu A, Mosseveld M, Rijnbeek P, Weibel D, Verhamme K, Sturkenboom MCJM.

Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):612-620. doi: 10.1002/pds.4413. Epub 2018 Apr 24.

16.

Choice of time period to identify confounders for propensity score matching, affected the estimate: a retrospective cohort study of drug effectiveness in asthmatic children.

Osokogu OU, Khan J, Nakato S, Weibel D, de Ridder M, Sturkenboom MCJM, Verhamme K.

J Clin Epidemiol. 2018 Sep;101:107-115.e3. doi: 10.1016/j.jclinepi.2018.01.008. Epub 2018 Feb 27.

PMID:
29378305
17.

Is patient exposure preapproval and postapproval a determinant of the timing and frequency of occurrence of safety issues?

Pacurariu AC, Hoeve CE, Arlett P, Genov G, Slattery J, Sturkenboom MCJM, Straus SMJM.

Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):168-173. doi: 10.1002/pds.4359. Epub 2017 Dec 26.

PMID:
29278866
18.

Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: A systematic review and meta-analysis.

Man KKC, Chan EW, Ip P, Coghill D, Simonoff E, Chan PKL, Lau WCY, Schuemie MJ, Sturkenboom MCJM, Wong ICK.

Neurosci Biobehav Rev. 2018 Mar;86:1-11. doi: 10.1016/j.neubiorev.2017.12.007. Epub 2017 Dec 13.

PMID:
29247762
19.

Brand and generic use of inhalation medication and frequency of switching in children and adults: A population-based cohort study.

Engelkes M, van Blijderveen JC, Overbeek JA, Kuiper J, Herings RCM, Sturkenboom MCJM, de Jongste JC, Verhamme KMC, Janssens HM.

J Asthma. 2018 Oct;55(10):1086-1094. doi: 10.1080/02770903.2017.1396468. Epub 2017 Nov 29.

PMID:
29185812
20.

Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project.

Poluzzi E, Diemberger I, De Ridder M, Koci A, Clo M, Oteri A, Pecchioli S, Bezemer I, Schink T, Pilgaard Ulrichsen S, Boriani G, Sturkenboom MCJ, De Ponti F, Trifirò G.

Eur J Clin Pharmacol. 2017 Nov;73(11):1499-1510. doi: 10.1007/s00228-017-2317-0. Epub 2017 Aug 22.

PMID:
28831527
21.

Association of Risk of Suicide Attempts With Methylphenidate Treatment.

Man KKC, Coghill D, Chan EW, Lau WCY, Hollis C, Liddle E, Banaschewski T, McCarthy S, Neubert A, Sayal K, Ip P, Schuemie MJ, Sturkenboom MCJM, Sonuga-Barke E, Buitelaar J, Carucci S, Zuddas A, Kovshoff H, Garas P, Nagy P, Inglis SK, Konrad K, Häge A, Rosenthal E, Wong ICK.

JAMA Psychiatry. 2017 Oct 1;74(10):1048-1055. doi: 10.1001/jamapsychiatry.2017.2183.

22.

Baseline incidence of intussusception in early childhood before rotavirus vaccine introduction, the Netherlands, January 2008 to December 2012.

Gadroen K, Kemmeren JM, Bruijning-Verhagen PC, Straus SM, Weibel D, de Melker HE, Sturkenboom MC.

Euro Surveill. 2017 Jun 22;22(25). pii: 30556. doi: 10.2807/1560-7917.ES.2017.22.25.30556.

23.

CodeMapper: semiautomatic coding of case definitions. A contribution from the ADVANCE project.

Becker BFH, Avillach P, Romio S, van Mulligen EM, Weibel D, Sturkenboom MCJM, Kors JA; ADVANCE consortium.

Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):998-1005. doi: 10.1002/pds.4245. Epub 2017 Jun 28.

24.

Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study.

Man KKC, Chan EW, Ip P, Coghill D, Simonoff E, Chan PKL, Lau WCY, Schuemie MJ, Sturkenboom MCJM, Wong ICK.

BMJ. 2017 May 31;357:j2350. doi: 10.1136/bmj.j2350.

25.

Use of azithromycin and risk of ventricular arrhythmia.

Trifirò G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S, Mazzaglia G, Bezemer I, Garbe E, Schink T, Poluzzi E, Frøslev T, Molokhia M, Diemberger I, Sturkenboom MCJM.

CMAJ. 2017 Apr 18;189(15):E560-E568. doi: 10.1503/cmaj.160355.

26.

Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases.

Ferrajolo C, Verhamme KM, Trifirò G, 't Jong GW, Picelli G, Giaquinto C, Mazzaglia G, Stricker BH, Rossi F, Capuano A, Sturkenboom MC.

Drug Saf. 2017 Apr;40(4):305-315. doi: 10.1007/s40264-016-0493-y.

27.

Evaluating the Safety Profile of Non-Active Implantable Medical Devices Compared with Medicines.

Pane J, Coloma PM, Verhamme KM, Sturkenboom MC, Rebollo I.

Drug Saf. 2017 Jan;40(1):37-47. doi: 10.1007/s40264-016-0474-1. Review.

28.

Decision making in drug safety-a literature review of criteria used to prioritize newly detected safety issues.

Pacurariu AC, Coloma PM, Gross-Martirosyan L, Sturkenboom MC, Straus SM.

Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):327-334. doi: 10.1002/pds.4128. Epub 2016 Nov 23. Review.

PMID:
27878889
29.

Evaluation of a multinational, multilingual vaccine debate on Twitter.

Becker BF, Larson HJ, Bonhoeffer J, van Mulligen EM, Kors JA, Sturkenboom MC.

Vaccine. 2016 Dec 7;34(50):6166-6171. doi: 10.1016/j.vaccine.2016.11.007. Epub 2016 Nov 10.

PMID:
27840012
30.

Are proton-pump inhibitors harmful for the semen quality of men in couples who are planning pregnancy?

Huijgen NA, de Ridder MA, Verhamme KM, Dohle GR, Vanrolleghem AM, Sturkenboom MC, Laven JS, Steegers-Theunissen RP.

Fertil Steril. 2016 Dec;106(7):1666-1672.e2. doi: 10.1016/j.fertnstert.2016.09.010. Epub 2016 Oct 12.

PMID:
27743698
31.

Real life data on incidence and risk factors of severe asthma exacerbations in children in primary care.

Engelkes M, Janssens HM, de Ridder MA, Sturkenboom MC, de Jongste JC, Verhamme KM.

Respir Med. 2016 Oct;119:48-54. doi: 10.1016/j.rmed.2016.08.016. Epub 2016 Aug 23.

32.

The variability in beta-cell function in placebo-treated subjects with type 2 diabetes: application of the weight-HbA1c-insulin-glucose (WHIG) model.

Duong JK, de Winter W, Choy S, Plock N, Naik H, Krauwinkel W, Visser SA, Verhamme KM, Sturkenboom MC, Stricker BH, Danhof M.

Br J Clin Pharmacol. 2017 Mar;83(3):487-497. doi: 10.1111/bcp.13144. Epub 2016 Nov 17.

33.

Using Prescription Patterns in Primary Care to Derive New Quality Indicators for Childhood Community Antibiotic Prescribing.

de Bie S, Kaguelidou F, Verhamme KM, De Ridder M, Picelli G, Straus SM, Giaquinto C, Stricker BH, Bielicki J, Sharland M, Sturkenboom MC; ARPEC study.

Pediatr Infect Dis J. 2016 Dec;35(12):1317-1323.

PMID:
27626915
34.

Patterns of spontaneous reports on narcolepsy following administration of pandemic influenza vaccine; a case series of individual case safety reports in Eudravigilance.

Gadroen K, Straus SMJM, Pacurariu A, Weibel D, Kurz X, Sturkenboom MCJM.

Vaccine. 2016 Sep 22;34(41):4892-4897. doi: 10.1016/j.vaccine.2016.08.062. Epub 2016 Aug 28.

PMID:
27577558
35.

Pharmacoepidemiological safety studies in children: a systematic review.

Osokogu OU, Dukanovic J, Ferrajolo C, Dodd C, Pacurariu AC, Bramer WM, 'tJong G, Weibel D, Sturkenboom MC, Kaguelidou F.

Pharmacoepidemiol Drug Saf. 2016 Aug;25(8):861-70. doi: 10.1002/pds.4041. Epub 2016 Jun 3. Review.

36.

Drug Safety Monitoring in Children: Performance of Signal Detection Algorithms and Impact of Age Stratification.

Osokogu OU, Dodd C, Pacurariu A, Kaguelidou F, Weibel D, Sturkenboom MC.

Drug Saf. 2016 Sep;39(9):873-81. doi: 10.1007/s40264-016-0433-x.

37.

Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs.

Oteri A, Mazzaglia G, Pecchioli S, Molokhia M, Ulrichsen SP, Pedersen L, Poluzzi E, De Ponti F, Garbe E, Schink T, Herings R, Bezemer ID, Sturkenboom MC, Trifirò G.

Br J Clin Pharmacol. 2016 Aug;82(2):487-97. doi: 10.1111/bcp.12955. Epub 2016 May 18. Erratum in: Br J Clin Pharmacol. 2017 Jun;83(6):1360.

38.

Prescription patterns, adherence and characteristics of non-adherence in children with asthma in primary care.

Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MC, Verhamme KM.

Pediatr Allergy Immunol. 2016 Mar;27(2):201-8. doi: 10.1111/pai.12507. Epub 2015 Dec 21.

PMID:
26928754
39.

Hospital Admissions, Transfers and Costs of Guillain-Barré Syndrome.

van Leeuwen N, Lingsma HF, Vanrolleghem AM, Sturkenboom MC, van Doorn PA, Steyerberg EW, Jacobs BC.

PLoS One. 2016 Feb 9;11(2):e0143837. doi: 10.1371/journal.pone.0143837. eCollection 2016.

40.

Use of oral contraceptives in three European countries: a population-based multi-database study.

Bezemer ID, Verhamme KM, Gini R, Mosseveld M, Rijnbeek PR, Trifirò G, Sturkenboom MC, Penning-van Beest FJ, Herings RM.

Eur J Contracept Reprod Health Care. 2016;21(1):81-7. doi: 10.3109/13625187.2015.1102220. Epub 2015 Oct 22.

PMID:
26492444
41.

Application of a Systems Pharmacology-Based Placebo Population Model to Analyze Long-Term Data of Postmenopausal Osteoporosis.

Berkhout J, Stone JA, Verhamme KM, Stricker BH, Sturkenboom MC, Danhof M, Post TM.

CPT Pharmacometrics Syst Pharmacol. 2015 Sep;4(9):516-26. doi: 10.1002/psp4.12006. Epub 2015 Aug 22.

42.

Response to comment on: "antibiotic use varies substantially among adults--a cross‑national study from five European Countries in the ARITMO project".

Mor A, Thomsen RW, Frøslev T, Garbe E, Poluzzi E, Sturkenboom MC, Trifirò G, Søgaard M.

Infection. 2016 Feb;44(1):135-41. doi: 10.1007/s15010-015-0829-z. Epub 2015 Sep 16. No abstract available.

PMID:
26377832
43.

Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.

Pacurariu AC, Straus SM, Trifirò G, Schuemie MJ, Gini R, Herings R, Mazzaglia G, Picelli G, Scotti L, Pedersen L, Arlett P, van der Lei J, Sturkenboom MC, Coloma PM.

Drug Saf. 2015 Dec;38(12):1201-10. doi: 10.1007/s40264-015-0341-5.

44.

Erratum to: Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project.

Mor A, Frøslev T, Thomsen RW, Oteri A, Rijnbeek P, Schink T, Garbe E, Pecchioli S, Innocenti F, Bezemer I, Poluzzi E, Sturkenboom MC, Trifirò G, Søgaard M.

Infection. 2016 Feb;44(1):145-50. doi: 10.1007/s15010-015-0835-1. No abstract available.

PMID:
26358972
45.

Incidence of microscopic colitis in relation to the number of colonoscopies over time.

Masclee GM, Coloma PM, Kuipers EJ, Sturkenboom MC.

Am J Gastroenterol. 2015 Aug;110(8):1246-7. doi: 10.1038/ajg.2015.189. No abstract available.

PMID:
26263369
46.

Evaluating Social Media Networks in Medicines Safety Surveillance: Two Case Studies.

Coloma PM, Becker B, Sturkenboom MC, van Mulligen EM, Kors JA.

Drug Saf. 2015 Oct;38(10):921-30. doi: 10.1007/s40264-015-0333-5.

47.

Adverse drug reactions in a primary care population prescribed non-steroidal anti-inflammatory drugs.

Koffeman AR, Van Buul AR, Valkhoff VE, Jong GW, Bindels PJ, Sturkenboom MC, Van der Lei J, Luijsterburg PA, Bierma-Zeinstra SM.

Scand J Prim Health Care. 2015;33(3):163-9. doi: 10.3109/02813432.2015.1067513. Epub 2015 Jul 22.

48.

Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project.

de Bie S, Ferrajolo C, Straus SM, Verhamme KM, Bonhoeffer J, Wong IC, Sturkenboom MC; GRiP network.

PLoS One. 2015 Jun 19;10(6):e0130399. doi: 10.1371/journal.pone.0130399. eCollection 2015.

49.

The narcolepsy-pandemic influenza story: can the truth ever be unraveled?

Sturkenboom MC.

Vaccine. 2015 Jun 8;33 Suppl 2:B6-B13. doi: 10.1016/j.vaccine.2015.03.026. Review.

PMID:
26022571
50.

Trends in paediatric macrolide use in five European countries-a population-based study.

Holstiege J, Enders D, Schink T, Innocenti F, Oteri A, Bezemer I, Kaguelidou F, Molokhia M, Poluzzi E, Puccini A, Ulrichsen SP, Sturkenboom MC, Trifirò G, Garbe E.

Eur J Clin Pharmacol. 2015 Aug;71(8):991-9. doi: 10.1007/s00228-015-1870-7. Epub 2015 May 22.

PMID:
25998220

Supplemental Content

Loading ...
Support Center